Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Elanco Animal Health Inc
(NY:
ELAN
)
13.04
-0.27 (-2.03%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Elanco Animal Health Inc
< Previous
1
2
3
Next >
Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health
February 29, 2024
From
Ancora Holdings Group, LLC
Via
Business Wire
Merck Animal Health to Acquire Elanco’s Aqua Business
February 05, 2024
From
Merck & Co., Inc.
Via
Business Wire
Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in Evercore ISI 6th Annual HealthCONx Conference
November 27, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Animal Health Reports Third Quarter 2023 Results
November 07, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Athian and Elanco Animal Health Team Up to Transform Food Production through Methane Reduction
November 02, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Confirms Date and Conference Call for Third Quarter 2023 Financial Results Announcement
October 17, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Announces Corporate Governance Enhancements
October 04, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease
September 07, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 05, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Animal Health Reports Second Quarter 2023 Results and Raises Full Year Guidance
August 07, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Releases 2022 Environmental, Social and Governance Report, Demonstrating Sustainability Progress in Internal Operations and Customer Collaborations
July 20, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Confirms Date and Conference Call for Second Quarter 2023 Financial Results Announcement
July 18, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Environmental Protection Agency (EPA) Completes Review of Seresto® Collar and Confirms Continued Registration; Data Affirms Safety Profile of the Product
July 13, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Bullish or Bearish? Vetting Animal Health Care Stocks
June 16, 2023
Americans are paying more and more attention to pet health, making pet care stocks look healthy again. Here are two names worth a check up.
Via
MarketBeat
Topics
ETFs
Elanco to Participate in Goldman Sachs 44th Annual Global Healthcare Conference
June 05, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in Stifel 2023 Jaws and Paws Conference
May 25, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Zoetis Declares New Dividend, Hinting At Undervaluation
May 18, 2023
Zoetis shareholders woke up to news of JAB's acquisition of Pumpkin, a per insurance platform where Zoetis owns a minority stake. 2023 outlooks suggest a rally
Via
MarketBeat
Elanco Animal Health Reports First Quarter 2023 Results
May 09, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Announces Breakthrough Treatment for Deadly Canine Parvovirus
May 02, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Confirms Date and Conference Call for First Quarter 2023 Financial Results Announcement
April 18, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in the Barclays Global Healthcare Conference
March 09, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in the Cowen 43rd Annual Health Care Conference
February 27, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in the Bank of America 2023 Animal Health Summit
February 23, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Animal Health Reports Fourth Quarter and Full Year 2022 Results
February 21, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Adds Animal Health Veteran to Executive Committee
February 20, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
February 16, 2023
Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024.
Via
MarketBeat
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2022 Financial Results Announcement
February 03, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco to Participate in the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Elanco Animal Health Incorporated
Via
Business Wire
Elanco Announces FDA Approval of Bexacat™ (bexagliflozin tablets) – the First-of-its-Kind Oral Feline Diabetes Treatment Option
December 09, 2022
From
Elanco Animal Health Incorporated
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.